Gus Bilirakis actually said...
How is it possible for CMS to prejudge an entire class of drugs as not being reasonable and necessary for seniors after the FDA approves these very drugs to treat a safe and effective--for Medicare patients with Alzheimer's, the primary audience for these drugs?
Context
Questioning CMS's decision to block Alzheimer's drug coverage despite FDA approval.
03/28/2023